Tranilast, an antifibrotic agent and COVID-19-induced pulmonary fibrosis.

Oshitani, N; Watanabe, K; Sakuma, T; Matsuda, M; Oyama, Y

Oshitani, N; Watanabe, K; Sakuma, T; Matsuda, M; Oyama, Y.

Oshitani N; Department of Internal Medicine, Social Welfare Service Corporation Ishii Memorial Aizen-en, Aizenbashi Infirmary, Osaka, Japan.
Watanabe K; Department of Internal Medicine, Social Welfare Service Corporation Ishii Memorial Aizen-en, Aizenbashi Infirmary, Osaka, Japan.
Sakuma T; Department of Internal Medicine, Social Welfare Service Corporation Ishii Memorial Aizen-en, Aizenbashi Infirmary, Osaka, Japan.
Matsuda M; Department of Internal Medicine, Social Welfare Service Corporation Ishii Memorial Aizen-en, Aizenbashi Infirmary, Osaka, Japan.
Oyama Y; Department of Radiology, Social Welfare Service Corporation Ishii Memorial Aizen-en, Aizenbashi Infirmary, Osaka, Japan.

QJM ; 115(4): 249-250, 2022 04 20.

Article in English | MEDLINE | ID: covidwho-1735652

Subject(s)

COVID-19; Pulmonary Fibrosis; Fibrosis; Humans; Pulmonary Fibrosis/drug therapy; Pulmonary Fibrosis/etiology; ortho-Aminobenzoates/pharmacology; ortho-Aminobenzoates/therapeutic use

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Pulmonary Fibrosis / COVID-19 Limits: Humans Language: English Journal: QJM Journal subject: Medicine Year: 2022 Document Type: Article Affiliation country: Qjmed

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google